Met Life Investment Management, LLC Harvard Bioscience Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$4.02 - $5.39 $85,027 - $114,003
21,151 New
21,151 $89,000
Q3 2023

May 09, 2024
BUY
$4.0 - $5.82 $83,204 - $121,061
20,801 New
20,801 $89,000
Q2 2023

Apr 29, 2024
BUY
$4.19 - $6.16 $87,156 - $128,134
20,801 New
20,801 $114,000
Q2 2023

Aug 10, 2023
BUY
$4.19 - $6.16 $87,156 - $128,134
20,801 New
20,801 $114,000
Q2 2022

Aug 11, 2022
SELL
$3.28 - $6.42 $55,218 - $108,080
-16,835 Closed
0 $0
Q1 2022

May 10, 2024
BUY
$5.16 - $7.14 $86,868 - $120,201
16,835 New
16,835 $104,000
Q1 2022

Jun 20, 2023
BUY
$5.16 - $7.14 $86,868 - $120,201
16,835 New
16,835 $104,000
Q1 2022

Mar 22, 2023
BUY
$5.16 - $7.14 $10,371 - $14,351
2,010 Added 13.56%
16,835 $104,000
Q1 2022

May 12, 2022
BUY
$5.16 - $7.14 $10,371 - $14,351
2,010 Added 13.56%
16,835 $105,000
Q4 2021

Jun 21, 2023
BUY
$6.37 - $8.18 $94,435 - $121,268
14,825 New
14,825 $104,000
Q3 2021

May 17, 2024
SELL
$6.98 - $8.47 $44,155 - $53,581
-6,326 Reduced 29.91%
14,825 $103,000
Q3 2021

Jun 21, 2023
BUY
$6.98 - $8.47 $103,478 - $125,567
14,825 New
14,825 $103,000
Q3 2021

Mar 22, 2023
BUY
$6.98 - $8.47 $103,478 - $125,567
14,825 New
14,825 $103,000
Q3 2021

Nov 15, 2021
BUY
$6.98 - $8.47 $103,478 - $125,567
14,825 New
14,825 $103,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email